NECTAR LIFESCIENCES
Back to Income Statement
|
NECTAR LIFESCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-114 Cr | ₹5.00 Cr | ₹-24 Cr | ₹25 Cr | ₹-73 Cr |
What is the latest Consolidated Net Profit of NECTAR LIFESCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-114 Cr |
| Mar2024 | ₹5.00 Cr |
| Mar2023 | ₹-24 Cr |
| Mar2022 | ₹25 Cr |
| Mar2021 | ₹-73 Cr |
How is Consolidated Net Profit of NECTAR LIFESCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-114 Cr | Negative | |
| Mar2024 | ₹5.00 Cr | Positive | |
| Mar2023 | ₹-24 Cr | Negative | |
| Mar2022 | ₹25 Cr | Positive | |
| Mar2021 | ₹-73 Cr | - | |
Compare Consolidated Net Profit of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹330.4 Cr | -0.9% | 8.4% | -56.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,419.0 Cr | 3.5% | 6.2% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,857.0 Cr | -2.7% | -0.7% | 11% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,953.0 Cr | 0.6% | 9.1% | 19.7% | Stock Analytics | |
| CIPLA | ₹123,722.0 Cr | 1.2% | -1.4% | -4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,906.0 Cr | 3.9% | 0.6% | -3.7% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -0.9% |
8.4% |
-56.5% |
| SENSEX | 1.6% |
2.7% |
6.3% |
You may also like the below Video Courses